Pharmacological modulation of connexin-formed channels in cardiac pathophysiology
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological modulation of connexin-formed channels in cardiac pathophysiology
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 163, Issue 3, Pages 469-483
Publisher
Wiley
Online
2011-01-26
DOI
10.1111/j.1476-5381.2011.01244.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Postconditioning and protection from reperfusion injury: where do we stand? * Position Paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology
- (2010) M. Ovize et al. CARDIOVASCULAR RESEARCH
- Gap junctions and connexins as therapeutic targets in cancer
- (2010) Mustapha Kandouz et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Design and characterization of the first peptidomimetic molecule that prevents acidification-induced closure of cardiac gap junctions
- (2010) Vandana Verma et al. HEART RHYTHM
- Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes
- (2010) Dennis Rottlaender et al. JOURNAL OF CLINICAL INVESTIGATION
- Long-Term Outcome of a Routine Versus Selective Invasive Strategy in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome
- (2010) Keith A.A. Fox et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Connexin 43 mimetic peptide Gap26 confers protection to intact heart against myocardial ischemia injury
- (2010) Ghayda Hawat et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Cardiac Gap Junction Channels Are Upregulated by Metoprolol: An Unexpected Effect of Beta-Blockers
- (2010) Aida Salameh et al. PHARMACOLOGY
- The effect of enhanced gap junctional conductance on ventricular conduction in explanted hearts from patients with heart failure
- (2009) Rob F. Wiegerinck et al. BASIC RESEARCH IN CARDIOLOGY
- Connexin43 phosphorylation: structural changes and biological effects
- (2009) Joell L. Solan et al. BIOCHEMICAL JOURNAL
- Discovery of a class of potent gap-junction modifiers as novel antiarrhythmic agents
- (2009) Eugene L. Piatnitski Chekler et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The signal transduction cascade regulating the expression of the gap junction protein connexin43 by β-adrenoceptors
- (2009) A Salameh et al. BRITISH JOURNAL OF PHARMACOLOGY
- Connexin43 in cardiomyocyte mitochondria contributes to mitochondrial potassium uptake
- (2009) Elisabet Miro-Casas et al. CARDIOVASCULAR RESEARCH
- Human cardiac gap-junction coupling: effects of antiarrhythmic peptide AAP10
- (2009) Anja Hagen et al. CARDIOVASCULAR RESEARCH
- Ca2+ regulation of connexin 43 hemichannels in C6 glioma and glial cells
- (2009) Elke De Vuyst et al. CELL CALCIUM
- Connexin-related signaling in cell death: to live or let die?
- (2009) E Decrock et al. CELL DEATH AND DIFFERENTIATION
- Novel Pharmacophores of Connexin43 Based on the “RXP” Series of Cx43-Binding Peptides
- (2009) Vandana Verma et al. CIRCULATION RESEARCH
- Effects of Chronic Gap Junction Conduction–Enhancing Antiarrhythmic Peptide GAP-134 Administration on Experimental Atrial Fibrillation in Dogs
- (2009) Gabriel Laurent et al. Circulation-Arrhythmia and Electrophysiology
- Discontinued drugs in 2008: cardiovascular drugs
- (2009) Zhang Xu-song et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- GAP-134 ([2S,4R]-1-[2-Aminoacetyl]4-Benzamidopyrrolidine-2-Carboxylic Acid) Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs
- (2009) James K. Hennan et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Discovery of (2S,4R)-1-(2-Aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic Acid Hydrochloride (GAP-134)13, an Orally Active Small Molecule Gap-Junction Modifier for the Treatment of Atrial Fibrillation
- (2009) John A. Butera et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Gap Junction Modifier, GAP-134 [(2S,4R)-1-(2-Aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic Acid], Improves Conduction and Reduces Atrial Fibrillation/Flutter in the Canine Sterile Pericarditis Model
- (2009) E. I. Rossman et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Improving cardiac gap junction communication as a new antiarrhythmic mechanism: the action of antiarrhythmic peptides
- (2009) Stefan Dhein et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Connexins in Vascular Physiology and Pathology
- (2008) Anne C. Brisset et al. ANTIOXIDANTS & REDOX SIGNALING
- Remodelling of gap junctions and connexin expression in diseased myocardium
- (2008) N. J. Severs et al. CARDIOVASCULAR RESEARCH
- Connexin 43 hemichannels contribute to the propagation of apoptotic cell death in a rat C6 glioma cell model
- (2008) E Decrock et al. CELL DEATH AND DIFFERENTIATION
- RXP-E
- (2008) Rebecca Lewandowski et al. CIRCULATION RESEARCH
- ATP release by cardiac myocytes in a simulated ischaemia model
- (2008) Thomas C. Clarke et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Connexin 43 Hemichannels Are Permeable to ATP
- (2008) J. Kang et al. JOURNAL OF NEUROSCIENCE
- Local effects and mechanisms of antiarrhythmic peptide AAP10 in acute regional myocardial ischemia: electrophysiological and molecular findings
- (2008) Joanna Jozwiak et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Cardiac Connections — The Antiarrhythmic Solution?
- (2008) Heather S. Duffy NEW ENGLAND JOURNAL OF MEDICINE
- Gap junctions: multifaceted regulators of embryonic cortical development
- (2008) Laura A.B. Elias et al. TRENDS IN NEUROSCIENCES
- Purinergic signalling
- (2006) Geoffrey Burnstock BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now